AdaptDx Pro Guided by Theia Launched for Dark Adaptation Testing

 AdaptDx Pro Guided by Theia Launched for Dark Adaptation Testing

MacuLogix®, Inc., has introduced AdaptDx Pro™ guided by Theia™, an automated dark adaptometer for dark adaptation functional testing. The company’s original AdaptDx® adaptometer was first introduced in 2014 and has since been used by more than 1,000 eye care professionals to identify and monitor AMD.

The new AdaptDx Pro headset was custom-designed and tested for patient comfort and includes all the functionality and accuracy of the company’s table-top dark adaptometer. As a self-contained wearable headset, the AdaptDx Pro requires no darkroom or external computer and features an artificial intelligence-driven onboard technician named Theia.™  After the in-office technician selects the testing protocol and places the device on the patient’s head, Theia takes over to facilitate a reliable, consistent testing experience by using automated instructions and adaptive feedback spoken directly to the patient.

Impaired dark adaptation is the earliest biomarker of AMD. Often manifested as night vision problems, this functional impairment becomes apparent years before drusen are visible. Therefore, assessing how well patients’ eyes can adapt from bright light to darkness makes it possible to detect AMD at a subclinical stage. AdaptDx Pro guided by Theia is a revolutionary new way to measure dark adaptation in a clinical setting quickly and effectively, using an objective, functional measurement called the Rod Intercept™ (RI™). Importantly, impaired dark adaptation as measured by the AdaptDx Pro is 90% specific and sensitive to AMD.

“Patients and staff love Theia. Her gentle coaching, combined with the well-designed, comfortable headset puts patients at ease and frees up technicians while testing takes place,” says MacuLogix’s clinical advisor Jeffry Gerson, OD, FAAO. “Ultimately, the AdaptDx Pro enables us to test more patients to find disease that we may have otherwise missed and start those patients on a treatment plan to slow disease progression.”

Years of development went into creating this one-of-a-kind medical device to improve the testing experience and make modern AMD management practical in almost any optometry or ophthalmology office.

The AdaptDx Pro launches today and the company has committed to providing current AdaptDx table-top device owners with the first opportunity to upgrade to the AdaptDx Pro. Eye care professionals can experience the AdaptDx Pro guided by Theia in person and learn about purchase and subscription pricing options at variety of local and national events, including SECO (Booth 838) and Vision Expo East (Booth MS4733) or online at www.maculogix.com.

Full press release: https://www.maculogix.com/news-events/maculogix-introduces-the-adaptdx-pro-guided-by-theia/

Source: MacuLogix

  • <<
  • >>

Comments